4BIO Capital
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space. For more information, please visit www.4biocapital.com
London, England, United Kingdom
Venture Capital and Private Equity Principals
Private Equity
—
No verticals classified
Biotech, Venture Capital, Private Equity, Non-discretionary advice
—
—
20
2014
Triage: pure_vc — VC firm investing in early-stage biotech companies
Prospects
No prospects linked to this account.
Outreach History
Outreach sequencing tables are not yet in Supabase.